Mulakan
Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc.

Tiada dagangan
Lihat pada Carta Super
Gambaran keseluruhan Kewangan
Dokumen
Perbincangan Teknikal Bermusim

Pemfailan SEC dan dokumen lain Navidea Biopharmaceuticals, Inc.


Terokai dokumen syarikat terkini dan pemfailan SEC dari Navidea Biopharmaceuticals, Inc., termasuk Forms 10-K, 10-Q, 8-K dan pendedahan utama lain. Nilaikan prestasi kewangan dan kemas kini pengoperasian untuk melakukan keputusan lebih termaklum.
Rakan kongsi data
Huraian
Reported date
Borang
2023
Q3 2023
Nov 14, 2023
Quarterly report10-Q
Earnings release8-K
Q2 2023
Ogos 11, 2023
Quarterly report10-Q
Earnings release8-K
Q1 2023
Jun 07, 2023
Earnings release8-K
2022
Q4 2022
Mac 21, 2023
Annual report10-K
Earnings release8-K
Q3 2022
Nov 15, 2022
Quarterly report10-Q
Earnings release8-K
Q2 2022
Sep 08, 2022
Earnings release8-K
2021
Q4 2021
Mac 28, 2022
Annual report10-K
2020
Q4 2020
Mac 26, 2021
Annual report10-K
2019
Q4 2019
Mac 18, 2020
Annual report10-K
2018
Q4 2018
Mac 15, 2019
Annual report10-K
2017
Q4 2017
Mac 15, 2018
Annual report10-K
2016
Q4 2016
Mac 31, 2017
Annual report10-K
2015
Q4 2015
Mac 23, 2016
Annual report10-K
2014
Q4 2014
Mac 16, 2015
Annual report10-K